IND Swift Laboratories

IND Swift Laboratories Interest Coverage

The Interest Coverage Ratio of IND Swift Laboratories (INDSWFTLAB.NS) as of Oct 16, 2026 is 5.53. In the previous year, Interest Coverage Ratio was 14.14 — a change of -60.91% (lower).

Interest Coverage

5.53

YoY

-60.91%

Last updated:

Interest Coverage Ratio of IND Swift Laboratories is 2025 5.53 . Interest Coverage Ratio of IND Swift Laboratories was 2024 14.14 . It decreases by -60.91% lower compared to the previous year.

The IND Swift Laboratories Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2018
2.43 INR
Jan 1, 2019
1.85 INR
Jan 1, 2020
0.83 INR
Jan 1, 2021
1.32 INR
Jan 1, 2022
1.20 INR
Jan 1, 2023
2.85 INR
Jan 1, 2024
14.14 INR
Jan 1, 2025
5.53 INR
The IND Swift Laboratories Interest Coverage history
YEARInterest CoverageYoY
5.53-60.91%
14.14+396.46%
2.85+136.75%
1.20-8.49%
1.32+58.98%
0.83-55.18%
1.85-24.10%
2.43-403.36%
-0.80-16.26%
-0.96-35.55%
-1.49-16.78%
-1.78—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

IND Swift Laboratories Stock analysis

What does IND Swift Laboratories do? IND Swift Laboratories Ltd is a pharmaceutical company based in Chandigarh, India, operating within the healthcare sector. The company specializes in the manufacturing, development, and marketing of pharmaceutical ingredients, including intermediates and formulations. It employs 1,496 full-time employees and went public via an IPO on March 15, 2002. IND Swift Laboratories serves as an API (Active Pharmaceutical Ingredient) partner for various organizations in both generic and innovative pharmaceutical domains. The company provides reference standards and impurities for multiple active pharmaceutical ingredients (APIs), adhering to standards such as the British Pharmacopoeia (BP) and European Pharmacopoeia (EP). Its product portfolio includes over 25 APIs, with all impurities supplied alongside comprehensive documentation, including Certificates of Analysis and Material Safety Data Sheets (MSDS). The firm maintains a research center spanning 40,000 square feet, dedicated to developing process technology for APIs across various therapeutic categories. The company's website is www.indswiftlabs.com, and it operates under the ticker symbol INDSWFTLAB.NS with ISIN INE915B01019. IND Swift Laboratories focuses on supplying high-quality pharmaceutical components to support global pharmaceutical manufacturing needs. IND Swift Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IND Swift Laboratories stock

Interest Coverage Ratio of IND Swift Laboratories is 5.53 in 2025.

Interest Coverage Ratio of IND Swift Laboratories changed from 14.14 to 5.53, representing a -60.91% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio IND Swift Laboratories since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's IND Swift Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — IND Swift Laboratories

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — IND Swift Laboratories